Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: MarketLine (a Datamonitor Company)
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sonic Healthcare Ltd reaffirms FY 2014 EBITDA guidance


Monday, 17 Feb 2014 09:00pm EST 

Sonic Healthcare Ltd:Says that it gave FY 2014 guidance in Aug 2013 of EBITDA growth of about 5 pct over the FY 2013 level of A$647 million, on a Constant Currency basis.After seven months of trading the Company is on track to achieve this guidance. 

Company Quote

18.17
0.06 +0.33%
12:25am EDT